Literature DB >> 6609198

Partial purification and characterization of a BCGFII from EL4 culture supernatants.

R W Dutton, G D Wetzel, S L Swain.   

Abstract

Two B cell growth factor activities have been previously described. One activity, present in the culture supernatants of PMA-induced EL4 is active in a co-stimulator assay with normal B cells and anti-immunoglobulin. The other activity is present in the culture supernatants of the alloreactive T cell line C.C3.11.75 and can be assayed in a co-stimulator assay with normal B cells and dextran sulfate or with BCL1 in vivo line B cell tumor. We have termed the first activity BCGFI and the second BCGFII. We have now shown that a very similar BCGFII activity can be obtained from EL4 culture supernatants induced by PMA. This (EL4)BCGFII has an apparent m.w. of 55,000, is eluted from DEAE Sephacel at 0.05 M NaCl, and has a pI of 5.5, which is clearly distinct from the properties of (EL4)BCGFI activity. (EL4)BCGFII activity is similar to but not identical to (DL)BCGFII. It differs from (DL)BCGFII in chromatographic behavior and in the kinetics of the response of BCL1 to the two factors. (EL4)BCGFII activity can be detected in 18 to 24 hr by virtue of its ability to cause in vitro proliferation of in vivo BCL1 tumor B cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609198

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4.

Authors:  C J Sanderson; A O'Garra; D J Warren; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

2.  Three functionally distinct helper T-cell clones: the roles for antigen non-specific helper factors in B-cell activation through two different pathways.

Authors:  Y Sano; N Harada; K Takatsu
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

Review 3.  Induction of antigen-specific antibody responses by nonspecific T cell-derived helper factors.

Authors:  M J Grusby; S K Pierce
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

Review 4.  Mechanisms of physiologic B cell responses and B cell hyperactivity in systemic lupus erythematosus.

Authors:  R H Zubler; Y P Huang; P A Miescher
Journal:  Springer Semin Immunopathol       Date:  1986

5.  B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation.

Authors:  A O'Garra; K P Rigley; M Holman; J B McLaughlin; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

6.  Engineering of a functional interleukin-5 monomer: a paradigm for redesigning helical bundle cytokines with therapeutic potential in allergy and asthma.

Authors:  R R Dickason; J D English; D P Huston
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

7.  A plant extract which enhances the plating efficiency of lymphoid cell lines and enhances the survival of normal lymphoid cells in vitro.

Authors:  C A Dunstan; J Andersson; L Bohlin; P A Cox; K O Grönvik
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

8.  In vivo adjuvant effect of interleukins 5 and 6 on rat tear IgA antibody responses.

Authors:  A G Pockley; P C Montgomery
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

9.  Role of T cells in the B-cell response: glutaraldehyde-fixed T-helper hybridoma cells synergize with the lymphokine IL-4 to induce B-cell activation and proliferation.

Authors:  E Kubota; D T McKenzie; R W Dutton; S L Swain
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

10.  The production of lymphokines by primary alloreactive T-cell clones: a co-ordinate analysis of 233 clones in seven lymphokine assays.

Authors:  C J Sanderson; M Strath; D J Warren; A O'Garra; T B Kirkwood
Journal:  Immunology       Date:  1985-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.